mRNA vaccines: Four major clinical trial readouts to watch in 2023

In 2023, four major trials in influenza, genital herpes, and melanoma will show just how far-reaching mRNA vaccine technology could be. These include Moderna’s mRNA-1010 and Pfizer’s modRNA vaccine in seasonal influenza, Roche/BioNTech’s RO7198457 in advanced melanoma, and BioNTech’s BNT-163 for lesions in genital herpes.